» Articles » PMID: 28306230

The Evidence-based Rationale for Physical Therapy Treatment of Children, Adolescents, and Adults Diagnosed with Joint Hypermobility Syndrome/hypermobile Ehlers Danlos Syndrome

Overview
Specialty Genetics
Date 2017 Mar 18
PMID 28306230
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

New insights into the phenotype of Joint Hypermobility Syndrome (JHS) and Ehlers-Danlos Syndrome-hypermobile type (hEDS) have raised many issues in relation to classification, diagnosis, assessment, and treatment. Within the multidisciplinary team, physical therapy plays a central role in management of individuals with hypermobility related disorders. However, many physical therapists are not familiar with the diagnostic criteria, prevalence, common clinical presentation, and management. This guideline aims to provide practitioners with the state of the art regarding the assessment and management of children, adolescents, and adults with JHS/hEDS. Due to the complexity of the symptoms in the profile of JHS/hEDS, the International Classification of Functioning, Disability and Health (ICF) is adopted as a central framework whereby the umbrella term of disability is used to encompass functions, activities and participation, as well as environmental and personal factors. The current evidence-based literature regarding the management of JHS/hEDS is limited in size and quality and there is insufficient research exploring the clinical outcomes of a number of interventions. Multicenter randomized controlled trials are warranted to assess the clinical and cost-effectiveness of interventions for children and adults. Until further multicenter trials are conducted, clinical decision-making should be based on theoretical and the current limited research evidence. For all individuals diagnosed with JHS/hEDS, international consensus and combined efforts to identify risk profiles would create a better understanding of the pathological mechanisms and the potential for optimizing health care for affected individuals. © 2017 Wiley Periodicals, Inc.

Citing Articles

Suspected Mitochondrial Dysfunction and Complex Pathophysiology in Fatal Hypermobile Ehlers-Danlos Syndrome: Insights from a Case Report and Post-Mortem Findings.

Shirvani A, Shirvani P, Jonah U, Moore B, Holick M Biomedicines. 2025; 13(2).

PMID: 40002882 PMC: 11852713. DOI: 10.3390/biomedicines13020469.


A case of massive hematoma: reflections on hypermobile Ehlers-Danlos syndrome.

Liu Q, Zeng G, Xiong Y, Xu C Front Med (Lausanne). 2025; 12:1514349.

PMID: 39981085 PMC: 11841416. DOI: 10.3389/fmed.2025.1514349.


Phenotypic Presentation of Children with Joint Hypermobility: Preclinical Signs.

Lamari M, Lamari N, de Medeiros M, de Araujo Filho G, Santos A, Giacomini M Children (Basel). 2025; 12(1).

PMID: 39857940 PMC: 11763381. DOI: 10.3390/children12010109.


Patient and parent knowledge, understanding, and concerns after a new diagnosis of Ehlers Danlos syndrome.

Jones J, Black L, Black W Orphanet J Rare Dis. 2024; 19(1):493.

PMID: 39736684 PMC: 11684232. DOI: 10.1186/s13023-024-03517-y.


Proprioception and its relationship with range of motion in hypermobile and normal mobile children.

Ituen O, Smits-Engelsman B, Ferguson G, Duysens J Exp Brain Res. 2024; 242(12):2727-2735.

PMID: 39377918 PMC: 11568987. DOI: 10.1007/s00221-024-06937-1.